Shyam Srivats —BIO-PROTOCOL

Home About Us

Archive

Anand Ravindran GlaxoSmithKline
1 protocol

HongLok Lung University of Hong Kong
61 protocols

Tim Smith University of Aberdeen
4 protocols

Vanesa Olivares-Illana Instituto de Física, Universidad Autónoma de San Luis Potosí
15 protocols

Reviewer

Shyam Srivats

Research scientist, University of California, San Francisco

Research focus

Cancer biology
Cancer biology, cell biology, immunology, cell therapy

Reviewer merit
Editor merit

Education

PhD

Publications

https://www.ncbi.nlm.nih.gov/pubmed/?term=shyam+srivats

3 Protocols reviewed

A Potent Vaccine Delivery System

Authors: Guangzu Zhao, Armira Azuar, Istvan Toth and Mariusz Skwarczynski, date: 04/05/2021, view: 2412, Q&A: 0

Most vaccines require co-delivery of an adjuvant in order to generate the desired immune responses. However, many currently available adjuvants are non-biodegradable, have limited efficacy, and/or poor safety profile. Thus, new adjuvants, or

...

More >

In vitro STING Activation with the cGAMP-STINGΔTM Signaling Complex

Authors: Yanpu He, Celestine Hong, Darrell J. Irvine, Jiahe Li and Paula T. Hammond, date: 02/05/2021, view: 2165, Q&A: 0

Activating the STING (stimulator of interferon genes) signaling pathway via administration of STING agonist cyclic GMP-AMP (cGAMP) has shown great promise in cancer immunotherapy. While state-of-the-art approaches have predominantly focused on the ...

More >

More protocols >